Kyverna May Be On Track To Bring First CAR-T For Autoimmune Disease To Market

 
• By Joseph Haas
  
Kyverna hopes to bring the first CAR-T product for autoimmune disease to market (Shutterstock)

More from Cell Therapies

More from Advanced Therapies